Mulmit

SAB Biotherapeutics, Inc.SAB Biotherapeutics, Inc.

SABS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-48,953,36313,273,683-0.79
2024-12-311,322,410-42,910,520-34,105,309-3.68
2023-12-312,238,991-38,075,320-42,193,786-7.64
2022-12-3123,904,181-28,917,617-18,740,804-4.31
2021-12-3160,876,078-13,393,203-17,144,531-0.63

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-17Kropotova AlexandraCHIEF MEDICAL OFFICER473
2026-06-25Kropotova AlexandraCHIEF MEDICAL OFFICER988
2026-03-24Kropotova AlexandraCHIEF MEDICAL OFFICER988
2026-02-03Sullivan Eddie JoePRESIDENT3,000,000
2026-02-03Reich Samuel JCEO4,800,000
2026-02-03Bausch Christoph LawrenceCHIEF OPERATING OFFICER1,800,000
2026-02-03Kropotova AlexandraCHIEF MEDICAL OFFICER2,400,000
2026-02-03To LucySee Remarks2,400,000
2026-01-05Jain Rita240,000
2026-01-05ZACCARDELLI DAVID240,000
2025-12-16SKYLER JAY S150,000
2025-12-16Polvino William James150,000

8-K events

FiledItems
2026-07-07Regulation FD disclosure · Financial statements and exhibits
2026-06-18Submission of matters to a vote
2026-05-04Entry into a material agreement · Financial statements and exhibits
2026-04-22Regulation FD disclosure · Financial statements and exhibits
2026-03-19Entry into a material agreement · Other events · Financial statements and exhibits
2026-03-10Regulation FD disclosure · Other events · Financial statements and exhibits
2026-01-12Regulation FD disclosure · Financial statements and exhibits
2026-01-07Officer or director change · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.